Mazyar Malakouti in Southlake, Texas

Home Texas Southlake

Mazyar Malakouti has Gastroenterology as his primary medical specialty. Their primary office is: 505 S Nolen Dr in Southlake, Texas.

They're a part of the: Texas Digestive Disease Consultants Pllc medical group which has around 524 members. You can call their office at 817-424-1525 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Texas Medical Branch At Galveston and graduated in 2013 (around 11 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Mazyar Malakouti Office Phone and Directions

Mazyar Malakouti
Texas Digestive Disease Consultants Pllc
505 S Nolen Dr
Southlake, Texas 76092
817-424-1525

Patient Ratings
Please rate your experience with Mazyar Malakouti below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 817-424-1525

Enter a starting address:

Healthcare Info for Mazyar Malakouti

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: University Of Texas Medical Branch At Galveston
Graduation Year: 2013
The Primary Medical Specialty for Mazyar Malakouti is listed as: Gastroenterology
Approximate Years of Experience: 11
PAC (PECOS ID)#: 0547566697
NPI #: 1962845305
NPI Created On: 04/16/2013
NPI Last Updated Listed as: 07/09/2019
Primary Taxonomy Code: 207R00000X
License Number:
R1079
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope
Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope
Control of bleeding of esophagus, stomach, and/or upper small bowel using an endoscope
Diagnostic examination of large bowel using an endoscope
Biopsy of large bowel using an endoscope
Removal of polyps or growths of large bowel using an endoscope
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $115

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787616523

Being Disputed:: No

Product Related: No

Payments Total: $110

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788872447

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Immunology

Name of Drug #1: REMICADE

Open Associated Drug #1: 57894-030-01

Drug or Biological: Biological

Product Category #2: Immunology

Name Of Drug #2:: STELARA

Associated Drug #2: 57894-060-03

Payments Total: $124

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795457073

Being Disputed:: No

Product Related: No

Payments Total: $113

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783666829

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Neuroscience

Name of Drug #1: ZEPOSIA

Open Associated Drug #1: 59572-820-30